FSTA and IYK stand out as popular choices for U.S. consumer staples exposure, yet they approach the same defensive theme differently. Both give investors a way to own companies providing essential goods like food, beverages, tobacco, and household items, but their underlying indexes, number of holdings, and fee structures set them apart. With factors like inflation trends, rate expectations, and consumer resilience influencing recent cycles, it helps to examine how these funds differ in sector focus, concentration levels, and overall efficiency when considering them side by side.
FSTA aims to match the MSCI USA IMI Consumer Staples 25/50 Index, a cap-weighted benchmark that spans most of the U.S. staples space. It holds around 100 stocks, extending from large leaders into mid- and smaller-cap names while staying almost entirely within consumer defensive areas. The portfolio leans heavily toward top positions, with Walmart, Costco, and Procter & Gamble together making up more than a third of assets. Other key names include KO, PEP, PM, and MDLZ. Its expense ratio of 0.08% ranks among the lowest available, and the fund has served as a core sector holding for over a decade. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
IYK follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index and has been around since 2000. It holds roughly 58 securities and qualifies as non-diversified, so exposure sits across fewer names. Top holdings overlap with FSTA but differ in weighting, featuring PG, KO, PM, PEP, and ALT. What sets it apart is the addition of healthcare distribution companies like CVS and MCK, which account for about 11% of the portfolio and move it away from pure staples exposure. The expense ratio is 0.38%.
Consumer staples often serve as a steady anchor during uncertain economic times because demand for necessities holds up better than discretionary spending. Recent periods have featured moderating yet persistent inflation, evolving rate outlooks, and mixed consumer sentiment, all of which affect rotations into or out of defensive areas. Within the sector, pricing power and volume trends at major producers have shaped results, while the healthcare names in IYK face separate regulatory pressures. Common risks involve input-cost margins, currency effects for global firms, and shifts in capital toward growth areas when sentiment improves. From what I see, these dynamics make careful comparison worthwhile.
Both funds have drawn defensive interest lately, though their results have varied based on portfolio makeup. IYK’s healthcare tilt and tobacco emphasis have occasionally supported stronger short-term moves, while FSTA’s broader mega-cap focus has delivered more consistent participation at lower cost. On risk measures, IYK has tended toward lower beta thanks to its healthcare component, whereas FSTA’s emphasis on Walmart and Costco aligns it more with retail trends. Over longer horizons, FSTA’s fee advantage and wider diversification position it as an efficient core holding, even if IYK’s narrower profile can provide distinct tactical exposure at times.
When evaluating options like these, I find it useful to run quick scans across multiple factors. Tickeron’s AI Screener lets me filter by industry, expense ratios, holding counts, and performance metrics in one place. This helps highlight structural differences without manual effort and supports more informed decisions on sector allocations.
Structural details point to a preference for FSTA over IYK. The lower expense ratio, larger and more diversified holdings, and cleaner staples focus without the healthcare overlay give it an edge for core, long-term exposure. While IYK can show competitive short-term momentum, FSTA’s efficiency and consistency as a true sector benchmark make it the stronger choice for most investors seeking steady defensive positioning. This view comes from data-driven analysis and is not personalized advice.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 70 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 265 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 30 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 79%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples